about
Guidelines for the use and interpretation of assays for monitoring autophagyCharacterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificityStructural variability of the ubiquitin specific protease DUSP-UBL double domainsPhosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatasesThe ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulationIsoform-specific localization of the deubiquitinase USP33 to the Golgi apparatusPhosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cellsAb initio protein modelling reveals novel human MIT domainsThe MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradationGrowth factors induce differential phosphorylation profiles of the Hrs-STAM complex: a common node in signalling networks with signal-specific propertiesAMSH is an endosome-associated ubiquitin isopeptidaseDysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceUbiquitin code assembly and disassemblyBreaking the chains: structure and function of the deubiquitinasesHrs function: viruses provide the clueActivation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery.Quantitative proteomic analysis of Parkin substrates in Drosophila neurons.Deubiquitinase activities required for hepatocyte growth factor-induced scattering of epithelial cells.Regulation of ErbB2 receptor status by the proteasomal DUB POH1.Membrane transport: deciphering fusion.Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.Calcium and calmodulin in membrane fusion.Regulation of intracellular membrane transport.Absolute Quantification of Endogenous Ras Isoform AbundanceThe myotubularin family of lipid phosphatases.A comparative study of band 3 aggregation in erythrocyte membranes by melittin and other cationic agents.Endocytosis: the DUB version.The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exitPhosphoinositides and the endocytic pathway.The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer.Emerging roles of deubiquitinases in cancer-associated pathways.Ubiquitin: same molecule, different degradation pathways.Met receptor: a moving target.Selective protein degradation in cell signalling.Cellular functions of the DUBs.Governance of endocytic trafficking and signaling by reversible ubiquitylation.Deubiquitylases from genes to organism.The demographics of the ubiquitin system.Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells.USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death.
P50
Q21996341-70860348-0DB2-41AC-91B3-F655B932C93CQ24291835-332A6BEC-BF82-4C76-A916-60FE2601F28FQ24293418-EC75B0C1-5924-47FF-B3A2-C9CCC5296ED3Q24298042-A67EAC3B-6D9D-4933-AE6E-608C80373E78Q24306674-29C714BC-FBC8-422D-85FF-9CDA8DCF071BQ24317741-59012195-4700-4F36-B2B6-73AB2FF6385FQ24318292-1376D927-24E3-4F68-94DB-B0755ECD951CQ24322870-F3BB20A6-2181-4A33-AF74-5D02F7DB0BA5Q24337922-58702168-88DD-4DC7-86FA-D37B7C85C2B3Q24532853-EC3E2150-7402-477E-B1F8-FCBFAABB21BAQ24676880-1B8B5BB9-FD17-4421-8C3B-7D63B3EFE8EEQ26799900-A9C742F8-D9BF-419A-A179-AA0FCEEFF664Q26827247-4F48A921-D32B-4C9C-AAF0-7CCC5888FCF6Q28131738-9180168E-4178-4556-84F7-333D78EED2D1Q28645815-42C664B1-442F-44A9-AD21-CE6F914F137BQ30159944-EDDFE710-1529-4300-A681-F33E60B478D2Q30844860-D306A866-FDBC-4E68-A325-AFAD7BA38C0BQ30872503-3C0CE4C1-2127-439B-8D55-7E58DB1C749EQ33444766-51470B58-DE16-4BCF-99A0-461826AF9AB4Q34078457-B0E85940-7AFD-4D50-9BAD-30512ADCC674Q35166709-72D8D276-18D2-4D1E-980B-5A39B3B1A2A6Q35197974-95AC9788-7444-482E-8FAA-CBD3BBE700ADQ35455158-554837CC-D246-455C-BCB1-8FC359B20D8CQ35839061-8D7BD47B-7E45-49A4-9CA7-34BF9A4101BEQ36302905-6D15C439-41EA-48F8-8F97-4ECF9EE5DB5EQ36417700-7BF51278-189A-45F5-BB8C-F071473A31FDQ36601432-15DA6EF5-6D9B-4C4D-93D3-0FABD40F6DC5Q37075932-E4494383-AC02-47A2-8EA7-DC876E36EC43Q37314660-FA28A7FE-D227-44C2-8131-A3FB849FDE94Q37514113-88700D61-A364-4000-BF15-8FB055813ECBQ37674364-D6D1AC13-E594-4D9B-923E-BC771B600E74Q37812727-287A93BC-04F3-4439-8F1C-ABB7171EE1BFQ37932212-3AD6B7EC-082D-4F24-9622-DD6907F5FE7FQ37985359-4FB4DE21-FB72-4DE4-B6F8-8B469243A64DQ37987409-D154B6A7-BB18-4D8A-8E97-A51823621369Q38043227-13E38CEA-37C3-4DD8-90C4-6246B0A03CB9Q38125278-5CCDEC8A-DDBF-4414-9FE7-E15D1DF27B62Q38439051-C0566A07-1C82-4D85-9696-E281793ADE5BQ38824402-F51C4FC2-8C6D-4E22-BCD3-B4394A059CF0Q38903534-EED2AB68-FA7F-4C96-BBB5-B112B252CCF9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Michael J Clague
@es
Michael J Clague
@nl
Michael J Clague
@sl
Michael J. Clague
@en
type
label
Michael J Clague
@es
Michael J Clague
@nl
Michael J Clague
@sl
Michael J. Clague
@en
prefLabel
Michael J Clague
@es
Michael J Clague
@nl
Michael J Clague
@sl
Michael J. Clague
@en
P1053
A-7199-2008
P106
P1153
26643206100
P21
P214
1464155042718672401296
P31
P3829
P496
0000-0003-3355-9479
P734
P735
P7859
viaf-1464155042718672401296